Delivery Order SPE2DB22D6029-SPE2DB24FU0SH

Award Date 4/18/24
Potential Completion Date 5/9/24
Potential Value $2.3K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) has awarded a delivery order contract valued at $12,595.00 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract is for the supply of 400 mg vials of the medication BENLYSTA. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025, which serves...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,896.00 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The contract is for the delivery of BENLYSTA 120 MG VIALS, a specialty pharmaceutical product, to support military treatment programs and facilities. This delivery order falls under a larger indefinite delivery contract (IDC) awarded solely to...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, to supply BENLYSTA 400 mg vials. The $1,259.50 award has a completion date of March 7, 2024 and does not use any set-aside designations. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA worth up to $999,999,999.00 through December 31, 2025, which...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $5,581.96 to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the supply of BENLYSTA 200 mg/mL syringes, a pharmaceutical product. This Delivery Order contract is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a range of...
The U.S. Defense Logistics Agency (DLA) awarded a $7,557 firm-fixed-price delivery order to AmerisourceBergen Drug Corp's Corporate Office division. The award is for the supply of 400 mg vials of the pharmaceutical product BENLYSTA. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical for providing a comprehensive range of medical commodities to military treatment programs and facilities...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 400 mg vials of the specialty pharmaceutical drug BENLYSTA. The $1,259.50 contract has a completion date of February 26, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is issued under an indefinite delivery contract (IDC) with a...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,259.50 to Amerisourcebergen Drug Corp, a subsidiary of the leading global pharmaceutical distributor Amerisourcebergen Corporation. The contract, which has a completion date of February 27, 2024, is for the supply of 400 mg vials of the drug BENLYSTA. Amerisourcebergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania, serves as a prime contractor providing a wide range...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 400 mg vials of the pharmaceutical BENLYSTA. The contract has a potential value of $1,259.50 and a completion date of March 26, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of BENLYSTA 400 MG VIALS to the Defense Logistics Agency (DLA). The contract, valued at $11,213.60, is a firm fixed price delivery order with a period of performance through July 11, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $1,259.50 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide BENLYSTA 400 MG vials. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA, which serves as the primary vehicle for the company to deliver pharmaceuticals and medical supplies to DLA...
  • SPE2DB22D6029
    Indefinite Delivery Contract
  • SPE2DB22D6029-SPE2DB24FU0SH
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $2,275.20 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of 4564318948 units of BENLYSTA 120 MG VIALS, with a period of performance through May 9, 2024. This award is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the main vehicle for the company to provide a wide range of pharmaceutical products and medical supplies to the Department of Defense globally. Amerisourcebergen also holds a smaller $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities. The contract award did not utilize any set-aside designations.

Generated 7/18/24, 9:27 AM